Outcomes of TB treatment by HIV status in national recording systems in Brazil, 2003-2008

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Sanchez, Mauro ^a   Bartholomay, Patricia ^b   Arakaki Sanchez, Denise ^b   Enarson, Donald ^c   Bissell, Karen ^c   Barreira, Draurio ^b   Harries, Anthony ^c   Kritski, Afrânio ^d  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b MINISTÉRIO DA SAÚDE   (Brazil)

^c INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BRAZIL; COHORT ANALYSIS; DATA BASE; DEATH; FEMALE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; OUTCOME ASSESSMENT; RACE DIFFERENCE; RETROSPECTIVE STUDY; SAMPLE; SEX RATIO; STATISTICAL MODEL; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULOSIS; AIDS RELATED COMPLEX; DOCUMENTATION; MIDDLE AGED;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; BRAZIL; DOCUMENTATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84858639678     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033129     Document Type: Article

References (23)

1. Ghebreyesus TA, Kazatchkine M, Sidibé M, Nakatani H, (2010) Tuberculosis and HIV: time for an intensified response. www.thelancet.com. DOI:10.1016/S0140-6736(10)60595-8.
2. Harries AD, Zachariah R, Corbett EL, Lawn SD, Santos-Filho ET, et al. (2010) The HIV-associated tuberculosis epidemic-when will we act? Available: www.thelancet.com. DOI:10.1016/S0140-6736(10)60409-6.
3. Brazilian Ministry of Health (2011) 2011 data - Available: http://portal.saude.gov.br/portal/arquivos/pdf/apres_padrao_pnct_2011.pdf. Accessed on June 05 2011.
4. Brazilian Ministry of Health (2011) Monitoraids - AIDS monitoring online system. Available: http://sistemas.aids.gov.br/monitoraids/. Accessed on June 05 2011.
5. World Health Organization (2004) Interim Policy On Collaborative Tb/HIV Activities. Available: http://whqlibdoc.who.int/hq/2004/who_htm_tb_2004.330.pdf. Acessed on Jan 12, 2012.
6. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S, (2006) Survival Rate and Risk Factors of Mortality Among HIV/Tuberculosis-Coinfected Patients With and Without Antiretroviral Therapy. J Acquir Immune Defic Syndr 43: 42-46.
7. Nahid P, Jarlsberg LG, Rudoy I, de Jong BC, Unger A, et al. (2011) Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis. BMC Infectious Diseases 11: 1.
8. Kwan CK, Ernst JD, (2011) HIV and Tuberculosis: a Deadly Human Syndemic. pp. 351-376 Clinical Microbiology Reviews, Vol. 24, No. 2.
9. Brazilian Ministry of Health (2010) STD and AIDS Epidemiological Bulletin, Year VI number 01. ISSN pp. 1517-1159.
10. Brazilian Ministry of Health - National Health Foundation (2002) Tuberculosis: Guide for Epidemiological Surveillance.
11. Brazilian Ministry of Health (2009) Decree number 59. Available: http://dtr2001.saude.gov.br/sas/PORTARIAS/Port2003/GM/GM-59.htm Accessed on Jan 12, 2012.
12. McNutt LA, Wu C, Xue X, Hafner JP, (2003) Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes. Am J Epidemiol 157: 940-943.
13. Brazilian Ministry of Health, Department of STD, AIDS and Viral Hepatitis (2010) Guidelines for Antiretroviral Therapy in HIV-infected adults, supplement II. Available: http://www.aids.gov.br/sites/default/files/suplemento_II_web.pdf. Accessed on Jan 12, 2012.
14. Swaminathan S, Padmapriyadarsini C, Narendran G, (2010) HIV-Associated Tuberculosis: Clinical Update. Clinical Infectious Diseases 50 (10): 1377-1386 DOI:10.1086/652147.
15. Miranda A, Morgan M, Jamal L, Laserson K, Barreira D, et al. (2007) Impact of Antiretroviral Therapy on the Incidence of Tuberculosis: The Brazilian Experience, 1995-2001. PLoS ONE 2 (9): e826 doi:10.1371/journal.pone.0000826.
16. Pacheco AG, Durovni B, Cavalcante SC, Lauria LM, Moore RD, et al. (2008) AIDS-Related Tuberculosis in Rio de Janeiro, Brazil. PLoS ONE 3 (9): e3132 doi:10.1371/journal.pone.0003132.
17. de Carvalho BM, Monteiro AJ, Pires Neto RJ, Grangeiro TB, Frota CC, (2008) Factors Related to HIV/Tuberculosis Coinfection in a Brazilian Reference Hospital. The Brazilian Journal of Infectious Diseases 12 (4): 281-286.
18. Miranda AE, Golub JE, Lucena FF, Maciel EN, Gurgel MF, et al. (2009) Tuberculosis and AIDS Co-Morbidity in Brazil: Linkage of the Tuberculosis and AIDS Databases. The Brazilian Journal of Infectious Diseases 13 (2): 137-141.
19. Carvalho ACC, DeRiemer K, Figueira MM, Brito Nunes Z, Araújo ROC, et al. (2002) Clinical presentation and survival of HIV seropositive and seronegative smear positive pulmonary tuberculosis patients form a university general hospital in Rio de Janeiro, Brazil. Mem Int Oswaldo Cruz 97 (8): 1225-1230.
20. Schmaltz CAS, Sant'Anna FM, Neves SC, Velasque LS, Lourenco MC, et al. (2009) Influence of HIV Infection on Mortality in a Cohort of Patients Treated for Tuberculosis in the Context of Wide Access to HAART, in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 52: 623-628.
21. São Paulo State Division of Tuberculosis Control (1998) Decree CIP 4. Available: http://www.cve.saude.sp.gov.br/htm/TB/portaria/Portaria_CIP4.pdf). Acessed on Jan 12, 2012.
22. Brazilian Ministry of Health (2009) Decree number 151. Available: http://www.aids.gov.br/sites/default/files/portaria151_2009.pdf. Acessed on Jan 12, 2012.
23. Brazilian Ministry of Health - Secretariat for Health Surveillance, Department of Epidemiological Surveillance (2011) Guidelines for Tuberculosis Control in Brazil.